ホーム > 鈴木裕之/ Suzuki, Hiroyuki

鈴木裕之

ALUMNI 2025年3月現在、筑波大学が主たる所属機関ではありません

Suzuki, Hiroyuki

東北大学 , 大学院医学系研究科 , 准教授
Tohoku University , Graduate School of Medicine , Associate Professor

http://www.md.tsukuba.ac.jp/epatho/

http://www.md.tsukuba.ac.jp/younginit/

オープンアクセス版の論文は「つくばリポジトリ」で読むことができます。

21. A Cancer-Specific Monoclonal Antibody against HER2 Exerts Antitumor Activities in Human Breast Cancer Xenograft Models. Mika K Kaneko; Hiroyuki Suzuki; Tomokazu Ohishi; Takuro Nakamura (+1 著者) Yukinari Kato
International journal of molecular sciences 25: (2024) Semantic Scholar
22. Development of a Sensitive Anti-Mouse CD39 Monoclonal Antibody (C39Mab-1) for Flow Cytometry and Western Blot Analyses. Yuki Okada; Hiroyuki Suzuki; Mika K Kaneko; Yukinari Kato
Monoclonal antibodies in immunodiagnosis and immunotherapy 43: 24 (2024) Semantic Scholar
23. Establishment of Anti-Dog Programmed Cell Death Ligand 1 Monoclonal Antibodies for Immunohistochemistry. Tsunenori Ouchida; Hiroyuki Suzuki; Tomohiro Tanaka; Mika K KanekoYukinari Kato
Monoclonal antibodies in immunodiagnosis and immunotherapy (2024) Semantic Scholar
24. Establishment of a Novel Cancer-Specific Anti-HER2 Monoclonal Antibody H2Mab-250/H2CasMab-2 for Breast Cancers Mika K Kaneko; Hiroyuki Suzuki; Tomokazu Ohishi; Tomohiro TanakaYukinari Kato
(2023)
25. Establishment of a Novel Anti-mouse CCR1 Monoclonal Antibody C₁Mab-6 Tsunenori Ouchida; Yu Isoda; Tomohiro Tanaka; Mika K. Kaneko (+1 著者) Yukinari Kato
(2023)
26. A Cancer-Specific Monoclonal Antibody against Podocalyxin Exerted Antitumor Activities in Pancreatic Cancer Xenografts Hiroyuki Suzuki; Tomokazu Ohishi; Tomohiro Tanaka; Mika K. KanekoYukinari Kato
International Journal of Molecular Sciences 25: 161 (2023) Semantic Scholar
27. Cx4Mab-1: A Novel Anti-Mouse CXCR4 Monoclonal Antibody for Flow Cytometry. Tsunenori Ouchida; Hiroyuki Suzuki; Tomohiro Tanaka; Mika K KanekoYukinari Kato
Monoclonal antibodies in immunodiagnosis and immunotherapy (2023)
28. Epitope Mapping of an Anti-ferret Podoplanin Monoclonal Antibody Using the PA Tag-Substituted Analysis. Yu Isoda; Mika K Kaneko; Tomohiro Tanaka; Hiroyuki SuzukiYukinari Kato
Monoclonal antibodies in immunodiagnosis and immunotherapy 42: 189 (2023) Semantic Scholar
29. A Rat Anti-Mouse CD39 Monoclonal Antibody for Flow Cytometry. Hiroyuki Suzuki; Tomohiro Tanaka; Yuma Kudo; Mayuki Tawara (+2 著者) Yukinari Kato
Monoclonal antibodies in immunodiagnosis and immunotherapy 42: 203 (2023) Semantic Scholar
30. Antitumor activities against breast cancers by an afucosylated anti‐HER2 monoclonal antibody H₂Mab‐77‐mG_2a‐f Tomohiro Tanaka; Hiroyuki Suzuki; Tomokazu Ohishi; Mika K. KanekoYukinari Kato
Cancer Science (2023) Semantic Scholar
31. A Cancer-Specific Monoclonal Antibody against Podocalyxin Exerted Antitumor Activities in Pancreatic Cancer Xenografts Hiroyuki Suzuki; Tomokazu Ohishi; Tomohiro Tanaka; Mika K. KanekoYukinari Kato
(2023)
32. A Humanized and Defucosylated Antibody against Podoplanin (humLpMab-23-f) Exerts Antitumor Activities in Human Lung Cancer and Glioblastoma Xenograft Models. Hiroyuki Suzuki; Tomokazu Ohishi; Mika K Kaneko; Yukinari Kato
Cancers 15: (2023) Semantic Scholar
33. Development of an Anti-EphB4 Monoclonal Antibody for Multiple Applications Against Breast Cancers Ren Nanamiya; Hiroyuki Suzuki; Mika K. Kaneko; Yukinari Kato
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy (2023) Semantic Scholar
34. PMab-301: An Anti-Giraffe Podoplanin Monoclonal Antibody for Immunohistochemistry Tsunenori Ouchida; Tomohiro Tanaka; Hiroyuki Suzuki; Mika K KanekoYukinari Kato
(2023)
35. Defucosylated Monoclonal Antibody (H2Mab-139-mG2a-f) Exerted Antitumor Activities in Mouse Xenograft Models of Breast Cancers against Human Epidermal Growth Factor Receptor 2. Hiroyuki Suzuki; Tomokazu Ohishi; Ren Nanamiya; Manabu Kawada (+1 著者) Yukinari Kato
Current issues in molecular biology 45: 7734 (2023) Semantic Scholar
36. A Cancer-Specific Monoclonal Antibody against HER2 for Breast Cancers Hiroyuki Suzuki; Mika K Kaneko; Yukinari Kato
(2023)
37. Promotion of squamous cell carcinoma tumorigenesis by oncogene-mediated THG-1/TSC22D4 phosphorylation. Nohara Goto; Hiroyuki Suzuki; Ling Zheng; Yasuhito Okano (+3 著者) Mitsuyasu Kato
Cancer science 114: 3972 (2023) Semantic Scholar
38. Development of Highly Sensitive Anti-Mouse HER2 Monoclonal Antibodies for Flow Cytometry Tsunenori Ouchida; Hiroyuki Suzuki; Tomohiro Tanaka; Mika K. KanekoYukinari Kato
International Journal of Translational Medicine 3: 310 (2023) Semantic Scholar
39. Establishment of a Novel Anti-Human CCR6 Monoclonal Antibody C₆Mab-19 with the High Binding Affinity in Flow Cytometry Tomohiro Tanaka; Kaishi Kitamura; Hiroyuki Suzuki; Mika K. KanekoYukinari Kato
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy (2023) Semantic Scholar
40. Development of a Novel Anti-CD44 Variant 8 Monoclonal Antibody C44Mab-94 against Gastric Carcinomas Hiroyuki Suzuki; Nohara Goto; Tomohiro Tanaka; Tsunenori Ouchida (+1 著者) Yukinari Kato
Antibodies 12: 45 (2023) Semantic Scholar

« 1 2 3 4 … 9 »

1. あなたのラボから薬を生み出すアカデミア創薬の実践 : all Japan体制の先端技術支援を利用した創薬の最前線善光, 龍哉; 辻川, 和丈 (担当:分担執筆, 範囲:CBIS法による高感度抗体の作製)
羊土社 2024年2月 (ISBN: 9784758104166)
2. がんゲノム医療時代の分子腫瘍学鈴木裕之; 後藤のはら; 加藤光保 (担当:分担執筆, 範囲:TGF-β経路)
文光堂 2022年4月
3. 炎症メディエーター TGF-β 鈴木,裕之; 青山,知恵; 加藤,光保 (担当:共著)
日本臨床 2009年5月
4. TGF-betaシグナル伝達系とがん治療鈴木裕之; 中条友香; 加藤光保 (担当:監修)
南山堂 2008年9月
5. TGF-βシグナル伝達とがん治療鈴木裕之; 中条友香; 加藤光保 (担当:分担執筆)
がんの分子標的治療 2008年6月
6. Negative regulation of the TGF-β family signal pathway by inhibitory Smads and their involvement in cancer and fibrosis. Itoh S; Suzuki H; Itoh F; Miyazono K; Kato M (担当:共著)
Humana Press Inc. 2008年
7. IGFBP 鈴木裕之; 加藤光保 (担当:監修)
サイトカイン・増殖因子用語ライブラリー / 羊土社 2005年3月
8. TGF-betaシグナルと疾患鈴木裕之; 宮園浩平 (担当:監修)
シグナル伝達研究2003 シグナル伝達研究2003 羊土社 2003年1月

1. THG-1 overexpression stabilizes β-catenin via antagonizing NRBP1 in esophageal squamous cell carcinoma Hwang, Jongchan; Suzuki, Hiroyuki; Zhang, Jing; Vasudevan, Prasanna; Dijke, Peter ten; Kato, Mitsuyasu
第79回日本癌学会学術総会 2020年10月1日
2. THG-1/TSC22D4による細胞老化の制御鈴木裕之; 加藤光保
第79回日本癌学会学術総会 2020年10月1日
3. THG-1はHIF-1alphaの安定化を介して腫瘍の進行を促進する鄭齢; 加藤, 光保; 鈴木裕之
第3回がん三次元培養研究会 2019年11月18日
4. Regulation of c-MYC transcriptional activity by transforming growth factor-beta 1–stimulated clone 22 Suzuki, SHiroyuki; Kato, Mitsuyasu
第78回日本癌学会学術総会 2019年9月26日
5. Screening of macrocyclic peptide against CD44 Goto, Nohara; HIPOLITO; CHRISTOPHER; Suzuki, Hiroyuki; Kato, Mitsuyasu
第78回日本癌学会学術総会 2019年9月26日
6. Oncogenic functions of TGFβ-stimulated clone-22 families
STINT Special Symposium on the Sweden-Japan 150 Anniversary Grant 2019年1月19日招待有り
7. Screening of macrocyclic peptide against CD44s Goto, Nohara; Yin, Yizhen; Hipolito, Christopher John; Suzuki, Hiroyuki; Suga, Hiroaki; Kato, Mitsuyasu; Heldin, Paraskevi; Constantinos Kolliopoulos; Karalis, Theodoros
第10回国際ペプチドシンポジウム／第55回ペプチド討論会 2018年12月3日
8. THG-1, a novel oncogene in tumor angiogenesis Zheng, Ling; Suzuki, Hiroyuki; Kato, Mitsuyasu
第41回日本分子生物学会年会 2018年11月28日
9. 乳がん細胞におけるGPNMBの幹細胞性誘導作用沖田結花里; 陳晨; 鈴木裕之; 加藤, 光保
第77回日本癌学会学術総会 2018年9月27日
10. 扁平上皮がん進展におけるTHG-1/Tsc22D4の機能鈴木裕之; 加藤, 光保
第77回日本癌学会学術総会 2018年9月27日
11. 3D imaging analysis of the promotion process from beta -catenin accumulated crypts to colonic adenomas in mice model Kase, Kazuo; Saito, Nobuko; Iwasaki, Hideaki; Hiroshima, Kenzo; Okita, Yukari; Watanabe, Yukihide; Suzuki, Hiroyuki; Kato, Mitsuyasu
日本癌学会学術総会 2018年9月27日
12. Roles of the interaction between THG-1 and NRBP1 in the development of esophageal squamous cell carcinoma Hwang, Jongchan; Miura, Mayuka; Suzuki, Hiroyuki; Djike, Peter ten; Kato, Mitsuyasu
Tsukuba Global Science Week 2018 2018年9月20日
13. 扁平上皮がんの発生病理鈴木裕之
第104回日本病理学会総会 2016年招待有り
14. Roles of THG-1/Tsc22D4 in squamous cell carcinoma development Hiroyuki Suzuki
Tsukuba-UCI Science Partnership Conference 2015年12月10日
15. Roles of THG-1/Tsc22D4 in squamous cell carcinoma development Hiroyuki Suzuki
Joint International Symposium on TGF-family and Cancer 2015年1月12日招待有り
16. Hypoxia and oxidative stress resistance in squamous cell carcinoma Hiroyuki Suzuki
Annual meeting of Hypoxia 2014年11月22日招待有り
17. Roles of THG-1/Tsc22D4 in tumor development Hiroyuki Suzuki
TGF-beta meeting, Netherland 2014 2014年5月9日
18. Roles of THG-1/Tsc22D4 in tumorigenesis Hiroyuki Suzuki
TGF-beta meeting, Sweden, 2013 2013年
19. TGF-β suppresses transcription of HO-1 gene through induction of MafK and Bach1. Yukari,Okita; Hiroyuki,Suzuki; Mitsuyasu,Kato
Leading Graduate Schools International Conference 2010年11月1日
20. Tsc-22 and TMEPAI; target genes of TGF-beta signaling possibly involved in cancer development Kato, M; Suzuki, H; Watanabe.Y; Itoh.S
*EMPTY*____ 2007年9月